http://www.mypharma-editions.com L'Info Industrie & Politique de Santé Wed, 15 Feb 2012 14:04:44 +0000 en hourly 1 http://wordpress.org/?v=3.3.1 http://www.mypharma-editions.com/des-instituts-europeens-de-recherche-sallient-contre-les-virus-emergents http://www.mypharma-editions.com/des-instituts-europeens-de-recherche-sallient-contre-les-virus-emergents#comments Wed, 15 Feb 2012 08:30:40 +0000 morgdave http://www.mypharma-editions.com/?p=23431 http://www.mypharma-editions.com/des-instituts-europeens-de-recherche-sallient-contre-les-virus-emergents/feed 0 http://www.mypharma-editions.com/supercalculateur-curie-vers-de-nouvelles-pistes-therapeutiques http://www.mypharma-editions.com/supercalculateur-curie-vers-de-nouvelles-pistes-therapeutiques#comments Tue, 14 Feb 2012 09:04:04 +0000 morgdave http://www.mypharma-editions.com/?p=23421 http://www.mypharma-editions.com/supercalculateur-curie-vers-de-nouvelles-pistes-therapeutiques/feed 0 http://www.mypharma-editions.com/maladies-auto-immunes-effimune-recoit-un-soutien-financier-de-lue-pour-le-projet-triad http://www.mypharma-editions.com/maladies-auto-immunes-effimune-recoit-un-soutien-financier-de-lue-pour-le-projet-triad#comments Mon, 13 Feb 2012 09:50:44 +0000 morgdave http://www.mypharma-editions.com/?p=23407 http://www.mypharma-editions.com/maladies-auto-immunes-effimune-recoit-un-soutien-financier-de-lue-pour-le-projet-triad/feed 0 http://www.mypharma-editions.com/cancers-de-lenfant-des-facteurs-de-susceptibilite-genetique-dans-les-tumeurs-dewing http://www.mypharma-editions.com/cancers-de-lenfant-des-facteurs-de-susceptibilite-genetique-dans-les-tumeurs-dewing#comments Mon, 13 Feb 2012 08:59:20 +0000 morgdave http://www.mypharma-editions.com/?p=23403 http://www.mypharma-editions.com/cancers-de-lenfant-des-facteurs-de-susceptibilite-genetique-dans-les-tumeurs-dewing/feed 0 http://www.mypharma-editions.com/vaccin-contre-la-dengue-un-anticorps-prometteur-caracterise http://www.mypharma-editions.com/vaccin-contre-la-dengue-un-anticorps-prometteur-caracterise#comments Fri, 10 Feb 2012 12:50:24 +0000 morgdave http://www.mypharma-editions.com/?p=23397 http://www.mypharma-editions.com/vaccin-contre-la-dengue-un-anticorps-prometteur-caracterise/feed 0 http://www.mypharma-editions.com/de-nouveaux-resultats-soulignent-limportance-des-genes-synaptiques-dans-lautisme http://www.mypharma-editions.com/de-nouveaux-resultats-soulignent-limportance-des-genes-synaptiques-dans-lautisme#comments Fri, 10 Feb 2012 08:46:00 +0000 morgdave http://www.mypharma-editions.com/?p=23390 http://www.mypharma-editions.com/de-nouveaux-resultats-soulignent-limportance-des-genes-synaptiques-dans-lautisme/feed 0 http://www.mypharma-editions.com/neurosciences-pfizer-et-licm-annoncent-une-collaboration-de-recherche-translationelle http://www.mypharma-editions.com/neurosciences-pfizer-et-licm-annoncent-une-collaboration-de-recherche-translationelle#comments Wed, 01 Feb 2012 15:55:41 +0000 morgdave http://www.mypharma-editions.com/?p=23306 http://www.mypharma-editions.com/neurosciences-pfizer-et-licm-annoncent-une-collaboration-de-recherche-translationelle/feed 0 http://www.mypharma-editions.com/diabete-de-type-2-la-regulation-de-lhorloge-biologique-en-cause http://www.mypharma-editions.com/diabete-de-type-2-la-regulation-de-lhorloge-biologique-en-cause#comments Mon, 30 Jan 2012 15:21:25 +0000 morgdave http://www.mypharma-editions.com/?p=23254 http://www.mypharma-editions.com/diabete-de-type-2-la-regulation-de-lhorloge-biologique-en-cause/feed 0 http://www.mypharma-editions.com/emploi-linra-recrute-51-chercheurs-en-2012 http://www.mypharma-editions.com/emploi-linra-recrute-51-chercheurs-en-2012#comments Sat, 28 Jan 2012 08:38:42 +0000 morgdave http://www.mypharma-editions.com/?p=23233 http://www.mypharma-editions.com/emploi-linra-recrute-51-chercheurs-en-2012/feed 0 http://www.mypharma-editions.com/pascale-briand-nommee-nouvelle-directrice-generale-de-la-n-r http://www.mypharma-editions.com/pascale-briand-nommee-nouvelle-directrice-generale-de-la-n-r#comments Wed, 25 Jan 2012 17:39:13 +0000 morgdave http://www.mypharma-editions.com/?p=23202 http://www.mypharma-editions.com/pascale-briand-nommee-nouvelle-directrice-generale-de-la-n-r/feed 1 http://www.mypharma-editions.com/grippenet-fr-un-nouveau-systeme-de-surveillance-de-la-grippe-sur-internet http://www.mypharma-editions.com/grippenet-fr-un-nouveau-systeme-de-surveillance-de-la-grippe-sur-internet#comments Wed, 25 Jan 2012 14:18:17 +0000 morgdave http://www.mypharma-editions.com/?p=23198 http://www.mypharma-editions.com/grippenet-fr-un-nouveau-systeme-de-surveillance-de-la-grippe-sur-internet/feed 0 http://www.mypharma-editions.com/diabete-de-type-2-roche-et-lihu-ican-partenaires-pour-identifier-des-voies-de-signalisation-et-des-cibles-moleculaires http://www.mypharma-editions.com/diabete-de-type-2-roche-et-lihu-ican-partenaires-pour-identifier-des-voies-de-signalisation-et-des-cibles-moleculaires#comments Wed, 25 Jan 2012 08:43:54 +0000 morgdave http://www.mypharma-editions.com/?p=23183 http://www.mypharma-editions.com/diabete-de-type-2-roche-et-lihu-ican-partenaires-pour-identifier-des-voies-de-signalisation-et-des-cibles-moleculaires/feed 0 http://www.mypharma-editions.com/maladies-infectieuses-et-parasitaires-inauguration-de-linstitut-pasteur-du-laos http://www.mypharma-editions.com/maladies-infectieuses-et-parasitaires-inauguration-de-linstitut-pasteur-du-laos#comments Tue, 24 Jan 2012 10:22:01 +0000 morgdave http://www.mypharma-editions.com/?p=23169 http://www.mypharma-editions.com/maladies-infectieuses-et-parasitaires-inauguration-de-linstitut-pasteur-du-laos/feed 0 http://www.mypharma-editions.com/unicancer-helene-esperou-nommee-directrice-du-projet-medico-scientifique-et-de-la-qualite http://www.mypharma-editions.com/unicancer-helene-esperou-nommee-directrice-du-projet-medico-scientifique-et-de-la-qualite#comments Mon, 23 Jan 2012 14:37:42 +0000 morgdave http://www.mypharma-editions.com/?p=23150 http://www.mypharma-editions.com/unicancer-helene-esperou-nommee-directrice-du-projet-medico-scientifique-et-de-la-qualite/feed 0 http://www.mypharma-editions.com/recherche-et-innovation-le-lir-presente-ses-grandes-orientations-pour-2012 http://www.mypharma-editions.com/recherche-et-innovation-le-lir-presente-ses-grandes-orientations-pour-2012#comments Fri, 20 Jan 2012 13:08:17 +0000 morgdave http://www.mypharma-editions.com/?p=23108 http://www.mypharma-editions.com/recherche-et-innovation-le-lir-presente-ses-grandes-orientations-pour-2012/feed 0 http://www.mypharma-editions.com/innovation-et-sante-lap-hp-et-cdc-entreprises-signent-une-convention-de-cooperation http://www.mypharma-editions.com/innovation-et-sante-lap-hp-et-cdc-entreprises-signent-une-convention-de-cooperation#comments Fri, 20 Jan 2012 12:44:05 +0000 morgdave http://www.mypharma-editions.com/?p=23100 http://www.mypharma-editions.com/innovation-et-sante-lap-hp-et-cdc-entreprises-signent-une-convention-de-cooperation/feed 0 http://www.mypharma-editions.com/depression-resistante-astrazeneca-et-la-fondation-fondamental-mettent-en-place-un-reseau-de-centres-experts http://www.mypharma-editions.com/depression-resistante-astrazeneca-et-la-fondation-fondamental-mettent-en-place-un-reseau-de-centres-experts#comments Fri, 20 Jan 2012 09:07:59 +0000 morgdave http://www.mypharma-editions.com/?p=23087 http://www.mypharma-editions.com/depression-resistante-astrazeneca-et-la-fondation-fondamental-mettent-en-place-un-reseau-de-centres-experts/feed 0 http://www.mypharma-editions.com/hybrigenics-depose-une-demande-detude-clinique-pour-linecalcitol-dans-la-leucemie-lymphoide-chronique-llc http://www.mypharma-editions.com/hybrigenics-depose-une-demande-detude-clinique-pour-linecalcitol-dans-la-leucemie-lymphoide-chronique-llc#comments Thu, 19 Jan 2012 13:22:46 +0000 morgdave http://www.mypharma-editions.com/?p=23082 http://www.mypharma-editions.com/hybrigenics-depose-une-demande-detude-clinique-pour-linecalcitol-dans-la-leucemie-lymphoide-chronique-llc/feed 0 http://www.mypharma-editions.com/pherecydes-pharma-obtient-un-financement-de-la-dga-pour-le-projet-pacoburns http://www.mypharma-editions.com/pherecydes-pharma-obtient-un-financement-de-la-dga-pour-le-projet-pacoburns#comments Thu, 19 Jan 2012 09:11:07 +0000 morgdave http://www.mypharma-editions.com/?p=23078 http://www.mypharma-editions.com/pherecydes-pharma-obtient-un-financement-de-la-dga-pour-le-projet-pacoburns/feed 0 http://www.mypharma-editions.com/genethon-fulvio-mavilio-nomme-directeur-scientifique http://www.mypharma-editions.com/genethon-fulvio-mavilio-nomme-directeur-scientifique#comments Tue, 17 Jan 2012 14:40:00 +0000 morgdave http://www.mypharma-editions.com/?p=23037 http://www.mypharma-editions.com/genethon-fulvio-mavilio-nomme-directeur-scientifique/feed 0 http://www.mypharma-editions.com/therapie-genique-resultats-encourageants-pour-la-gamma-sarcoglycanopathie http://www.mypharma-editions.com/therapie-genique-resultats-encourageants-pour-la-gamma-sarcoglycanopathie#comments Tue, 17 Jan 2012 08:32:34 +0000 morgdave http://www.mypharma-editions.com/?p=23029 http://www.mypharma-editions.com/therapie-genique-resultats-encourageants-pour-la-gamma-sarcoglycanopathie/feed 0 http://www.mypharma-editions.com/troubles-auditifs-sanofi-et-aviesan-signent-un-accord-de-recherche-translationnelle http://www.mypharma-editions.com/troubles-auditifs-sanofi-et-aviesan-signent-un-accord-de-recherche-translationnelle#comments Mon, 16 Jan 2012 16:53:08 +0000 morgdave http://www.mypharma-editions.com/?p=23025 http://www.mypharma-editions.com/troubles-auditifs-sanofi-et-aviesan-signent-un-accord-de-recherche-translationnelle/feed 0 http://www.mypharma-editions.com/lafssaps-lance-un-premier-appel-a-projets-de-recherche http://www.mypharma-editions.com/lafssaps-lance-un-premier-appel-a-projets-de-recherche#comments Thu, 12 Jan 2012 13:46:10 +0000 morgdave http://www.mypharma-editions.com/?p=22994 http://www.mypharma-editions.com/lafssaps-lance-un-premier-appel-a-projets-de-recherche/feed 1 http://www.mypharma-editions.com/biotechnologies-inserm-transfert-initiative-leve-335-millions-deuros http://www.mypharma-editions.com/biotechnologies-inserm-transfert-initiative-leve-335-millions-deuros#comments Thu, 12 Jan 2012 13:38:29 +0000 morgdave http://www.mypharma-editions.com/?p=22990 http://www.mypharma-editions.com/biotechnologies-inserm-transfert-initiative-leve-335-millions-deuros/feed 0 http://www.mypharma-editions.com/lanrs-est-devenue-une-agence-autonome-de-linserm-depuis-le-1er-janvier-2012 http://www.mypharma-editions.com/lanrs-est-devenue-une-agence-autonome-de-linserm-depuis-le-1er-janvier-2012#comments Thu, 12 Jan 2012 08:38:50 +0000 morgdave http://www.mypharma-editions.com/?p=22986 http://www.mypharma-editions.com/lanrs-est-devenue-une-agence-autonome-de-linserm-depuis-le-1er-janvier-2012/feed 1 http://www.mypharma-editions.com/oncologie-matwin-transfere-son-premier-projet-de-recherche-a-roche http://www.mypharma-editions.com/oncologie-matwin-transfere-son-premier-projet-de-recherche-a-roche#comments Tue, 10 Jan 2012 17:54:17 +0000 morgdave http://www.mypharma-editions.com/?p=22969 http://www.mypharma-editions.com/oncologie-matwin-transfere-son-premier-projet-de-recherche-a-roche/feed 0 http://www.mypharma-editions.com/le-declin-cognitif-apparaitrait-des-45-ans http://www.mypharma-editions.com/le-declin-cognitif-apparaitrait-des-45-ans#comments Fri, 06 Jan 2012 09:25:40 +0000 morgdave http://www.mypharma-editions.com/?p=22936 http://www.mypharma-editions.com/le-declin-cognitif-apparaitrait-des-45-ans/feed 1 http://www.mypharma-editions.com/inserm-anne-bisagni-nommee-directrice-deleguee-aupres-de-la-presidence-et-de-claire-giry-directrice-du-departement-des-partenariats-et-des-relations-exterieures http://www.mypharma-editions.com/inserm-anne-bisagni-nommee-directrice-deleguee-aupres-de-la-presidence-et-de-claire-giry-directrice-du-departement-des-partenariats-et-des-relations-exterieures#comments Fri, 06 Jan 2012 09:17:46 +0000 morgdave http://www.mypharma-editions.com/?p=22933 http://www.mypharma-editions.com/inserm-anne-bisagni-nommee-directrice-deleguee-aupres-de-la-presidence-et-de-claire-giry-directrice-du-departement-des-partenariats-et-des-relations-exterieures/feed 0 http://www.mypharma-editions.com/neovacs-letude-clinique-de-phase-iia-dans-la-polyarthrite-rhumatoide-atteint-ses-objectifs http://www.mypharma-editions.com/neovacs-letude-clinique-de-phase-iia-dans-la-polyarthrite-rhumatoide-atteint-ses-objectifs#comments Thu, 05 Jan 2012 08:27:09 +0000 morgdave http://www.mypharma-editions.com/?p=22929 http://www.mypharma-editions.com/neovacs-letude-clinique-de-phase-iia-dans-la-polyarthrite-rhumatoide-atteint-ses-objectifs/feed 1 http://www.mypharma-editions.com/maladie-de-parkinson-oncodesign-et-ipsen-vont-developper-de-nouveaux-agents-therapeutiques-contre-la-cible-lrrk2 http://www.mypharma-editions.com/maladie-de-parkinson-oncodesign-et-ipsen-vont-developper-de-nouveaux-agents-therapeutiques-contre-la-cible-lrrk2#comments Thu, 05 Jan 2012 07:58:45 +0000 morgdave http://www.mypharma-editions.com/?p=22926 http://www.mypharma-editions.com/maladie-de-parkinson-oncodesign-et-ipsen-vont-developper-de-nouveaux-agents-therapeutiques-contre-la-cible-lrrk2/feed 1 http://www.mypharma-editions.com/lymphome-larc-et-linca-financent-un-essai-clinique-evaluant-une-nouvelle-therapie-ciblee http://www.mypharma-editions.com/lymphome-larc-et-linca-financent-un-essai-clinique-evaluant-une-nouvelle-therapie-ciblee#comments Tue, 03 Jan 2012 17:03:35 +0000 morgdave http://www.mypharma-editions.com/?p=22908 http://www.mypharma-editions.com/lymphome-larc-et-linca-financent-un-essai-clinique-evaluant-une-nouvelle-therapie-ciblee/feed 0 http://www.mypharma-editions.com/recherche-clinique-10-centres-de-lutte-contre-le-cancer-labellises http://www.mypharma-editions.com/recherche-clinique-10-centres-de-lutte-contre-le-cancer-labellises#comments Thu, 22 Dec 2011 10:21:24 +0000 morgdave http://www.mypharma-editions.com/?p=22870 http://www.mypharma-editions.com/recherche-clinique-10-centres-de-lutte-contre-le-cancer-labellises/feed 0 http://www.mypharma-editions.com/la-diversite-genetique-cruciale-pour-notre-pharmacopee http://www.mypharma-editions.com/la-diversite-genetique-cruciale-pour-notre-pharmacopee#comments Tue, 20 Dec 2011 09:07:11 +0000 morgdave http://www.mypharma-editions.com/?p=22826 http://www.mypharma-editions.com/la-diversite-genetique-cruciale-pour-notre-pharmacopee/feed 0 http://www.mypharma-editions.com/essai-clinique-un-nouveau-traitement-cible-pour-les-synovialo-sarcomes http://www.mypharma-editions.com/essai-clinique-un-nouveau-traitement-cible-pour-les-synovialo-sarcomes#comments Thu, 15 Dec 2011 17:21:10 +0000 morgdave http://www.mypharma-editions.com/?p=22787 http://www.mypharma-editions.com/essai-clinique-un-nouveau-traitement-cible-pour-les-synovialo-sarcomes/feed 0 http://www.mypharma-editions.com/metastases-une-proteine-ouvre-de-nouvelles-perspectives-therapeutiques http://www.mypharma-editions.com/metastases-une-proteine-ouvre-de-nouvelles-perspectives-therapeutiques#comments Wed, 14 Dec 2011 08:55:28 +0000 morgdave http://www.mypharma-editions.com/?p=22752 http://www.mypharma-editions.com/metastases-une-proteine-ouvre-de-nouvelles-perspectives-therapeutiques/feed 0 http://www.mypharma-editions.com/trophos-echec-de-l%e2%80%99olesoxime-dans-un-essai-de-phase-iii-dans-la-sla http://www.mypharma-editions.com/trophos-echec-de-l%e2%80%99olesoxime-dans-un-essai-de-phase-iii-dans-la-sla#comments Tue, 13 Dec 2011 10:00:22 +0000 morgdave http://www.mypharma-editions.com/?p=22717 http://www.mypharma-editions.com/trophos-echec-de-l%e2%80%99olesoxime-dans-un-essai-de-phase-iii-dans-la-sla/feed 0 http://www.mypharma-editions.com/cancer-colorectal-decouverte-dun-gene-protecteur http://www.mypharma-editions.com/cancer-colorectal-decouverte-dun-gene-protecteur#comments Tue, 13 Dec 2011 09:24:24 +0000 morgdave http://www.mypharma-editions.com/?p=22712 http://www.mypharma-editions.com/cancer-colorectal-decouverte-dun-gene-protecteur/feed 0 http://www.mypharma-editions.com/vih-gilead-annonce-les-donnees-sur-deux-ans-dune-etude-pivot-de-phase-3-sur-lelvitegravir http://www.mypharma-editions.com/vih-gilead-annonce-les-donnees-sur-deux-ans-dune-etude-pivot-de-phase-3-sur-lelvitegravir#comments Mon, 12 Dec 2011 08:41:53 +0000 morgdave http://www.mypharma-editions.com/?p=22677 http://www.mypharma-editions.com/vih-gilead-annonce-les-donnees-sur-deux-ans-dune-etude-pivot-de-phase-3-sur-lelvitegravir/feed 1 http://www.mypharma-editions.com/la-vaccination-antigrippale-h1n1-protege-a-la-fois-la-femme-enceinte-et-le-nouveau-ne http://www.mypharma-editions.com/la-vaccination-antigrippale-h1n1-protege-a-la-fois-la-femme-enceinte-et-le-nouveau-ne#comments Tue, 06 Dec 2011 16:30:46 +0000 morgdave http://www.mypharma-editions.com/?p=22611 http://www.mypharma-editions.com/la-vaccination-antigrippale-h1n1-protege-a-la-fois-la-femme-enceinte-et-le-nouveau-ne/feed 0 http://www.mypharma-editions.com/unicancer-christian-cailliot-nomme-directeur-de-la-recherche http://www.mypharma-editions.com/unicancer-christian-cailliot-nomme-directeur-de-la-recherche#comments Tue, 06 Dec 2011 16:13:51 +0000 morgdave http://www.mypharma-editions.com/?p=22608 http://www.mypharma-editions.com/unicancer-christian-cailliot-nomme-directeur-de-la-recherche/feed 0 http://www.mypharma-editions.com/claude-bertrand-nomme-president-d%e2%80%99ariis http://www.mypharma-editions.com/claude-bertrand-nomme-president-d%e2%80%99ariis#comments Fri, 02 Dec 2011 15:18:49 +0000 morgdave http://www.mypharma-editions.com/?p=22566 http://www.mypharma-editions.com/claude-bertrand-nomme-president-d%e2%80%99ariis/feed 0 http://www.mypharma-editions.com/une-nouvelle-approche-pour-le-traitement-des-maladies-auto-immunes http://www.mypharma-editions.com/une-nouvelle-approche-pour-le-traitement-des-maladies-auto-immunes#comments Thu, 01 Dec 2011 13:39:05 +0000 morgdave http://www.mypharma-editions.com/?p=22542 http://www.mypharma-editions.com/une-nouvelle-approche-pour-le-traitement-des-maladies-auto-immunes/feed 0 http://www.mypharma-editions.com/cellectis-et-lefs-vont-inaugurer-leur-partenariat http://www.mypharma-editions.com/cellectis-et-lefs-vont-inaugurer-leur-partenariat#comments Fri, 25 Nov 2011 08:08:48 +0000 morgdave http://www.mypharma-editions.com/?p=22474 http://www.mypharma-editions.com/cellectis-et-lefs-vont-inaugurer-leur-partenariat/feed 0 http://www.mypharma-editions.com/nanobiotix-obtient-un-nouveau-financement-dun-million-deuros-doseo http://www.mypharma-editions.com/nanobiotix-obtient-un-nouveau-financement-dun-million-deuros-doseo#comments Wed, 23 Nov 2011 16:52:55 +0000 morgdave http://www.mypharma-editions.com/?p=22457 http://www.mypharma-editions.com/nanobiotix-obtient-un-nouveau-financement-dun-million-deuros-doseo/feed 0 http://www.mypharma-editions.com/cancers-de-l%e2%80%99ovaire-une-double-signature-predictive-de-l%e2%80%99agressivite-tumorale-et-de-la-reponse-au-traitement http://www.mypharma-editions.com/cancers-de-l%e2%80%99ovaire-une-double-signature-predictive-de-l%e2%80%99agressivite-tumorale-et-de-la-reponse-au-traitement#comments Wed, 23 Nov 2011 09:28:29 +0000 morgdave http://www.mypharma-editions.com/?p=22443 http://www.mypharma-editions.com/cancers-de-l%e2%80%99ovaire-une-double-signature-predictive-de-l%e2%80%99agressivite-tumorale-et-de-la-reponse-au-traitement/feed 0 http://www.mypharma-editions.com/pharnext-termine-le-recrutement-pour-son-essai-clinique-de-phase-ii-avec-son-1er-pleomedicament%e2%84%a2 http://www.mypharma-editions.com/pharnext-termine-le-recrutement-pour-son-essai-clinique-de-phase-ii-avec-son-1er-pleomedicament%e2%84%a2#comments Tue, 22 Nov 2011 08:59:50 +0000 morgdave http://www.mypharma-editions.com/?p=22418 http://www.mypharma-editions.com/pharnext-termine-le-recrutement-pour-son-essai-clinique-de-phase-ii-avec-son-1er-pleomedicament%e2%84%a2/feed 0 http://www.mypharma-editions.com/traitement-anti-vih-gilead-sciences-finalise-un-accord-avec-tibotec-pharmaceuticals http://www.mypharma-editions.com/traitement-anti-vih-gilead-sciences-finalise-un-accord-avec-tibotec-pharmaceuticals#comments Thu, 17 Nov 2011 08:39:05 +0000 morgdave http://www.mypharma-editions.com/?p=22333 http://www.mypharma-editions.com/traitement-anti-vih-gilead-sciences-finalise-un-accord-avec-tibotec-pharmaceuticals/feed 1 http://www.mypharma-editions.com/herpes-resultats-encourageants-grace-aux-meganucleases-de-cellectis http://www.mypharma-editions.com/herpes-resultats-encourageants-grace-aux-meganucleases-de-cellectis#comments Mon, 14 Nov 2011 07:55:51 +0000 morgdave http://www.mypharma-editions.com/?p=22247 http://www.mypharma-editions.com/herpes-resultats-encourageants-grace-aux-meganucleases-de-cellectis/feed 0 http://www.mypharma-editions.com/hepatite-alcoolique-severe-la-combinaison-de-deux-traitements-savere-efficace http://www.mypharma-editions.com/hepatite-alcoolique-severe-la-combinaison-de-deux-traitements-savere-efficace#comments Thu, 10 Nov 2011 16:32:22 +0000 morgdave http://www.mypharma-editions.com/?p=22210 http://www.mypharma-editions.com/hepatite-alcoolique-severe-la-combinaison-de-deux-traitements-savere-efficace/feed 0 http://www.mypharma-editions.com/sanofi-et-regeneron-resultats-preliminaires-positifs-de-phase-ii-dans-l%e2%80%99hypercholesterolemie-pour-un-anticorps-anti-pcsk9 http://www.mypharma-editions.com/sanofi-et-regeneron-resultats-preliminaires-positifs-de-phase-ii-dans-l%e2%80%99hypercholesterolemie-pour-un-anticorps-anti-pcsk9#comments Thu, 10 Nov 2011 08:23:43 +0000 morgdave http://www.mypharma-editions.com/?p=22201 http://www.mypharma-editions.com/sanofi-et-regeneron-resultats-preliminaires-positifs-de-phase-ii-dans-l%e2%80%99hypercholesterolemie-pour-un-anticorps-anti-pcsk9/feed 2 http://www.mypharma-editions.com/neovacs%c2%ae-succes-de-l%e2%80%99etude-de-phase-iii-sur-lifn%ce%b1-kinoide%c2%ae-dans-le-lupus http://www.mypharma-editions.com/neovacs%c2%ae-succes-de-l%e2%80%99etude-de-phase-iii-sur-lifn%ce%b1-kinoide%c2%ae-dans-le-lupus#comments Wed, 09 Nov 2011 09:19:48 +0000 morgdave http://www.mypharma-editions.com/?p=22176 http://www.mypharma-editions.com/neovacs%c2%ae-succes-de-l%e2%80%99etude-de-phase-iii-sur-lifn%ce%b1-kinoide%c2%ae-dans-le-lupus/feed 0 http://www.mypharma-editions.com/cancer-l%e2%80%99inca-met-en-ligne-une-base-de-donnees-des-projets-de-recherche http://www.mypharma-editions.com/cancer-l%e2%80%99inca-met-en-ligne-une-base-de-donnees-des-projets-de-recherche#comments Sat, 05 Nov 2011 09:03:11 +0000 morgdave http://www.mypharma-editions.com/?p=22110 http://www.mypharma-editions.com/cancer-l%e2%80%99inca-met-en-ligne-une-base-de-donnees-des-projets-de-recherche/feed 1 http://www.mypharma-editions.com/cancer-du-foie-transgene-et-jennerex-annoncent-l%e2%80%99inclusion-du-premier-patient-dans-un-essai-clinique-de-phase-iib-sur-jx594tg6006 http://www.mypharma-editions.com/cancer-du-foie-transgene-et-jennerex-annoncent-l%e2%80%99inclusion-du-premier-patient-dans-un-essai-clinique-de-phase-iib-sur-jx594tg6006#comments Fri, 04 Nov 2011 12:06:45 +0000 morgdave http://www.mypharma-editions.com/?p=22086 http://www.mypharma-editions.com/cancer-du-foie-transgene-et-jennerex-annoncent-l%e2%80%99inclusion-du-premier-patient-dans-un-essai-clinique-de-phase-iib-sur-jx594tg6006/feed 0 http://www.mypharma-editions.com/etude-du-vieillissement-inauguration-de-l%e2%80%99institut-de-la-longevite-charles-foix http://www.mypharma-editions.com/etude-du-vieillissement-inauguration-de-l%e2%80%99institut-de-la-longevite-charles-foix#comments Fri, 04 Nov 2011 10:37:53 +0000 morgdave http://www.mypharma-editions.com/?p=22084 http://www.mypharma-editions.com/etude-du-vieillissement-inauguration-de-l%e2%80%99institut-de-la-longevite-charles-foix/feed 0 http://www.mypharma-editions.com/rougeole-pourquoi-ce-virus-se-propage-si-rapidement http://www.mypharma-editions.com/rougeole-pourquoi-ce-virus-se-propage-si-rapidement#comments Thu, 03 Nov 2011 14:17:50 +0000 morgdave http://www.mypharma-editions.com/?p=22066 http://www.mypharma-editions.com/rougeole-pourquoi-ce-virus-se-propage-si-rapidement/feed 0 http://www.mypharma-editions.com/mucoviscidose-resultats-prometteurs-pour-kalydeco%e2%84%a2-de-vertex http://www.mypharma-editions.com/mucoviscidose-resultats-prometteurs-pour-kalydeco%e2%84%a2-de-vertex#comments Thu, 03 Nov 2011 10:02:27 +0000 morgdave http://www.mypharma-editions.com/?p=22047 http://www.mypharma-editions.com/mucoviscidose-resultats-prometteurs-pour-kalydeco%e2%84%a2-de-vertex/feed 0 http://www.mypharma-editions.com/medecine-regenerative-rajeunir-des-cellules-devient-possible http://www.mypharma-editions.com/medecine-regenerative-rajeunir-des-cellules-devient-possible#comments Wed, 02 Nov 2011 12:59:44 +0000 morgdave http://www.mypharma-editions.com/?p=22028 http://www.mypharma-editions.com/medecine-regenerative-rajeunir-des-cellules-devient-possible/feed 1 http://www.mypharma-editions.com/cancers-gynecologiques-lancement-d%e2%80%99un-programme-d%e2%80%99actions-integrees-de-recherche-pair http://www.mypharma-editions.com/cancers-gynecologiques-lancement-d%e2%80%99un-programme-d%e2%80%99actions-integrees-de-recherche-pair#comments Tue, 01 Nov 2011 10:27:40 +0000 morgdave http://www.mypharma-editions.com/?p=22004 http://www.mypharma-editions.com/cancers-gynecologiques-lancement-d%e2%80%99un-programme-d%e2%80%99actions-integrees-de-recherche-pair/feed 0 http://www.mypharma-editions.com/andre-syrota-elu-vice-president-de-science-europe http://www.mypharma-editions.com/andre-syrota-elu-vice-president-de-science-europe#comments Fri, 28 Oct 2011 08:01:28 +0000 morgdave http://www.mypharma-editions.com/?p=21956 http://www.mypharma-editions.com/andre-syrota-elu-vice-president-de-science-europe/feed 0 http://www.mypharma-editions.com/progeria-resultats-prometteurs-d%e2%80%99une-therapie-genique-chez-l%e2%80%99animal http://www.mypharma-editions.com/progeria-resultats-prometteurs-d%e2%80%99une-therapie-genique-chez-l%e2%80%99animal#comments Fri, 28 Oct 2011 07:56:48 +0000 morgdave http://www.mypharma-editions.com/?p=21953 http://www.mypharma-editions.com/progeria-resultats-prometteurs-d%e2%80%99une-therapie-genique-chez-l%e2%80%99animal/feed 0 http://www.mypharma-editions.com/biogen-idec-et-abbott-resultats-positifs-pour-le-daclizumab-hyp-dans-la-sclerose-en-plaques http://www.mypharma-editions.com/biogen-idec-et-abbott-resultats-positifs-pour-le-daclizumab-hyp-dans-la-sclerose-en-plaques#comments Mon, 24 Oct 2011 07:03:21 +0000 morgdave http://www.mypharma-editions.com/?p=21855 http://www.mypharma-editions.com/biogen-idec-et-abbott-resultats-positifs-pour-le-daclizumab-hyp-dans-la-sclerose-en-plaques/feed 1 http://www.mypharma-editions.com/un-gene-de-predisposition-commun-au-melanome-et-au-cancer-du-rein http://www.mypharma-editions.com/un-gene-de-predisposition-commun-au-melanome-et-au-cancer-du-rein#comments Fri, 21 Oct 2011 13:58:39 +0000 morgdave http://www.mypharma-editions.com/?p=21839 http://www.mypharma-editions.com/un-gene-de-predisposition-commun-au-melanome-et-au-cancer-du-rein/feed 0 http://www.mypharma-editions.com/myelome-multiple-ab-science-recrute-le-1er-patient-de-l%e2%80%99etude-de-phase-3-du-masitinib http://www.mypharma-editions.com/myelome-multiple-ab-science-recrute-le-1er-patient-de-l%e2%80%99etude-de-phase-3-du-masitinib#comments Mon, 17 Oct 2011 16:37:34 +0000 morgdave http://www.mypharma-editions.com/?p=21749 http://www.mypharma-editions.com/myelome-multiple-ab-science-recrute-le-1er-patient-de-l%e2%80%99etude-de-phase-3-du-masitinib/feed 0 http://www.mypharma-editions.com/therapie-genique-vers-l%e2%80%99utilisation-des-cellules-souches-adultes-ips http://www.mypharma-editions.com/therapie-genique-vers-l%e2%80%99utilisation-des-cellules-souches-adultes-ips#comments Thu, 13 Oct 2011 09:06:20 +0000 morgdave http://www.mypharma-editions.com/?p=21669 http://www.mypharma-editions.com/therapie-genique-vers-l%e2%80%99utilisation-des-cellules-souches-adultes-ips/feed 0 http://www.mypharma-editions.com/vih-l%e2%80%99efficacite-des-nouveaux-antiretroviraux-confirmee-chez-les-patients-en-echec-therapeutique http://www.mypharma-editions.com/vih-l%e2%80%99efficacite-des-nouveaux-antiretroviraux-confirmee-chez-les-patients-en-echec-therapeutique#comments Tue, 11 Oct 2011 13:10:03 +0000 morgdave http://www.mypharma-editions.com/?p=21605 http://www.mypharma-editions.com/vih-l%e2%80%99efficacite-des-nouveaux-antiretroviraux-confirmee-chez-les-patients-en-echec-therapeutique/feed 1 http://www.mypharma-editions.com/vers-un-vaccin-plus-sur-contre-la-maladie-dalzheimer http://www.mypharma-editions.com/vers-un-vaccin-plus-sur-contre-la-maladie-dalzheimer#comments Tue, 11 Oct 2011 07:17:16 +0000 morgdave http://www.mypharma-editions.com/?p=21587 http://www.mypharma-editions.com/vers-un-vaccin-plus-sur-contre-la-maladie-dalzheimer/feed 0 http://www.mypharma-editions.com/hybrigenics-et-servier-signent-un-accord-de-licence-et-de-recherche http://www.mypharma-editions.com/hybrigenics-et-servier-signent-un-accord-de-licence-et-de-recherche#comments Mon, 10 Oct 2011 08:44:29 +0000 morgdave http://www.mypharma-editions.com/?p=21576 http://www.mypharma-editions.com/hybrigenics-et-servier-signent-un-accord-de-licence-et-de-recherche/feed 0 http://www.mypharma-editions.com/cellules-souches-partenariat-entre-l%e2%80%99anr-et-l%e2%80%99institut-californien-pour-la-medecine-regenerative-cirm http://www.mypharma-editions.com/cellules-souches-partenariat-entre-l%e2%80%99anr-et-l%e2%80%99institut-californien-pour-la-medecine-regenerative-cirm#comments Tue, 04 Oct 2011 16:35:17 +0000 morgdave http://www.mypharma-editions.com/?p=21470 http://www.mypharma-editions.com/cellules-souches-partenariat-entre-l%e2%80%99anr-et-l%e2%80%99institut-californien-pour-la-medecine-regenerative-cirm/feed 0 http://www.mypharma-editions.com/neuropaludisme-des-mecanismes-de-type-allergique-impliques http://www.mypharma-editions.com/neuropaludisme-des-mecanismes-de-type-allergique-impliques#comments Tue, 04 Oct 2011 12:12:02 +0000 morgdave http://www.mypharma-editions.com/?p=21444 http://www.mypharma-editions.com/neuropaludisme-des-mecanismes-de-type-allergique-impliques/feed 0 http://www.mypharma-editions.com/prix-nobel-de-medecine-decerne-a-jules-hoffmann http://www.mypharma-editions.com/prix-nobel-de-medecine-decerne-a-jules-hoffmann#comments Tue, 04 Oct 2011 07:10:07 +0000 morgdave http://www.mypharma-editions.com/?p=21436 http://www.mypharma-editions.com/prix-nobel-de-medecine-decerne-a-jules-hoffmann/feed 0 http://www.mypharma-editions.com/le-prix-nobel-de-medecine-recompense-trois-chercheurs-sur-le-systeme-immunitaire http://www.mypharma-editions.com/le-prix-nobel-de-medecine-recompense-trois-chercheurs-sur-le-systeme-immunitaire#comments Mon, 03 Oct 2011 12:46:51 +0000 morgdave http://www.mypharma-editions.com/?p=21426 http://www.mypharma-editions.com/le-prix-nobel-de-medecine-recompense-trois-chercheurs-sur-le-systeme-immunitaire/feed 0 http://www.mypharma-editions.com/baxter-soumet-une-demande-damm-europeenne-pour-l%e2%80%99hyq-pour-les-immunodeficiences-primaires http://www.mypharma-editions.com/baxter-soumet-une-demande-damm-europeenne-pour-l%e2%80%99hyq-pour-les-immunodeficiences-primaires#comments Sat, 01 Oct 2011 07:55:25 +0000 morgdave http://www.mypharma-editions.com/?p=21401 http://www.mypharma-editions.com/baxter-soumet-une-demande-damm-europeenne-pour-l%e2%80%99hyq-pour-les-immunodeficiences-primaires/feed 1 http://www.mypharma-editions.com/recherche-vaccinale-l%e2%80%99union-europeenne-investit-30-millions-d%e2%80%99euros http://www.mypharma-editions.com/recherche-vaccinale-l%e2%80%99union-europeenne-investit-30-millions-d%e2%80%99euros#comments Thu, 29 Sep 2011 11:55:13 +0000 morgdave http://www.mypharma-editions.com/?p=21354 http://www.mypharma-editions.com/recherche-vaccinale-l%e2%80%99union-europeenne-investit-30-millions-d%e2%80%99euros/feed 0 http://www.mypharma-editions.com/francoise-dromer-de-l%e2%80%99institut-pasteur-laureate-du-prix-canetti-2011 http://www.mypharma-editions.com/francoise-dromer-de-l%e2%80%99institut-pasteur-laureate-du-prix-canetti-2011#comments Wed, 28 Sep 2011 14:12:52 +0000 morgdave http://www.mypharma-editions.com/?p=21330 http://www.mypharma-editions.com/francoise-dromer-de-l%e2%80%99institut-pasteur-laureate-du-prix-canetti-2011/feed 0 http://www.mypharma-editions.com/diabete-1ere-lignee-de-cellules-pancreatiques-humaines-productrices-et-secretrices-dinsuline http://www.mypharma-editions.com/diabete-1ere-lignee-de-cellules-pancreatiques-humaines-productrices-et-secretrices-dinsuline#comments Mon, 26 Sep 2011 12:36:23 +0000 morgdave http://www.mypharma-editions.com/?p=21243 http://www.mypharma-editions.com/diabete-1ere-lignee-de-cellules-pancreatiques-humaines-productrices-et-secretrices-dinsuline/feed 0 http://www.mypharma-editions.com/cancer-du-sein-metastatique-resultats-positifs-pour-le-t-dm1-un-medicament-experimental-de-roche http://www.mypharma-editions.com/cancer-du-sein-metastatique-resultats-positifs-pour-le-t-dm1-un-medicament-experimental-de-roche#comments Mon, 26 Sep 2011 07:36:36 +0000 morgdave http://www.mypharma-editions.com/?p=21240 http://www.mypharma-editions.com/cancer-du-sein-metastatique-resultats-positifs-pour-le-t-dm1-un-medicament-experimental-de-roche/feed 1 http://www.mypharma-editions.com/maladie-d%e2%80%99alzheimer-les-industriels-du-medicament-se-mobilisent http://www.mypharma-editions.com/maladie-d%e2%80%99alzheimer-les-industriels-du-medicament-se-mobilisent#comments Wed, 21 Sep 2011 08:42:09 +0000 morgdave http://www.mypharma-editions.com/?p=21138 http://www.mypharma-editions.com/maladie-d%e2%80%99alzheimer-les-industriels-du-medicament-se-mobilisent/feed 0 http://www.mypharma-editions.com/sanofi-pasteur-acquiert-l%e2%80%99exclusivite-mondiale-des-droits-pour-un-vaccin-et-un-traitement-contre-l%e2%80%99acne http://www.mypharma-editions.com/sanofi-pasteur-acquiert-l%e2%80%99exclusivite-mondiale-des-droits-pour-un-vaccin-et-un-traitement-contre-l%e2%80%99acne#comments Wed, 21 Sep 2011 07:03:27 +0000 morgdave http://www.mypharma-editions.com/?p=21122 http://www.mypharma-editions.com/sanofi-pasteur-acquiert-l%e2%80%99exclusivite-mondiale-des-droits-pour-un-vaccin-et-un-traitement-contre-l%e2%80%99acne/feed 0 http://www.mypharma-editions.com/autisme-integragen-presente-les-resultats-d%e2%80%99un-test-destine-a-l%e2%80%99identification-precoce http://www.mypharma-editions.com/autisme-integragen-presente-les-resultats-d%e2%80%99un-test-destine-a-l%e2%80%99identification-precoce#comments Tue, 20 Sep 2011 07:37:38 +0000 morgdave http://www.mypharma-editions.com/?p=21089 http://www.mypharma-editions.com/autisme-integragen-presente-les-resultats-d%e2%80%99un-test-destine-a-l%e2%80%99identification-precoce/feed 0 http://www.mypharma-editions.com/maladie-dalzheimer-un-medicament-suscite-l%e2%80%99espoir-dans-les-formes-precoces http://www.mypharma-editions.com/maladie-dalzheimer-un-medicament-suscite-l%e2%80%99espoir-dans-les-formes-precoces#comments Tue, 20 Sep 2011 07:15:08 +0000 morgdave http://www.mypharma-editions.com/?p=21085 http://www.mypharma-editions.com/maladie-dalzheimer-un-medicament-suscite-l%e2%80%99espoir-dans-les-formes-precoces/feed 0 http://www.mypharma-editions.com/cancer-roche-va-presenter-des-resultats-encourageants-sur-ses-traitements-experimentaux http://www.mypharma-editions.com/cancer-roche-va-presenter-des-resultats-encourageants-sur-ses-traitements-experimentaux#comments Mon, 19 Sep 2011 06:34:52 +0000 morgdave http://www.mypharma-editions.com/?p=21051 http://www.mypharma-editions.com/cancer-roche-va-presenter-des-resultats-encourageants-sur-ses-traitements-experimentaux/feed 0 http://www.mypharma-editions.com/paludisme-un-vaccin-francais-aux-resultats-prometteurs http://www.mypharma-editions.com/paludisme-un-vaccin-francais-aux-resultats-prometteurs#comments Sun, 18 Sep 2011 10:26:16 +0000 morgdave http://www.mypharma-editions.com/?p=21043 http://www.mypharma-editions.com/paludisme-un-vaccin-francais-aux-resultats-prometteurs/feed 0 http://www.mypharma-editions.com/maladies-du-cerveau-des-biomarqueurs-isotopiques-revelent-les-empreintes-de-proteines http://www.mypharma-editions.com/maladies-du-cerveau-des-biomarqueurs-isotopiques-revelent-les-empreintes-de-proteines#comments Sat, 17 Sep 2011 07:02:50 +0000 morgdave http://www.mypharma-editions.com/?p=21020 http://www.mypharma-editions.com/maladies-du-cerveau-des-biomarqueurs-isotopiques-revelent-les-empreintes-de-proteines/feed 0 http://www.mypharma-editions.com/parkinson-decouverte-d%e2%80%99une-mutation-genetique-liee-a-la-maladie http://www.mypharma-editions.com/parkinson-decouverte-d%e2%80%99une-mutation-genetique-liee-a-la-maladie#comments Fri, 16 Sep 2011 16:18:59 +0000 morgdave http://www.mypharma-editions.com/?p=21017 http://www.mypharma-editions.com/parkinson-decouverte-d%e2%80%99une-mutation-genetique-liee-a-la-maladie/feed 0 http://www.mypharma-editions.com/depression-un-marqueur-sanguin-pour-detecter-la-predisposition http://www.mypharma-editions.com/depression-un-marqueur-sanguin-pour-detecter-la-predisposition#comments Fri, 16 Sep 2011 12:13:37 +0000 morgdave http://www.mypharma-editions.com/?p=21007 http://www.mypharma-editions.com/depression-un-marqueur-sanguin-pour-detecter-la-predisposition/feed 0 http://www.mypharma-editions.com/lutte-contre-le-cancer-ge-healthcare-va-investir-un-milliard-de-dollars http://www.mypharma-editions.com/lutte-contre-le-cancer-ge-healthcare-va-investir-un-milliard-de-dollars#comments Fri, 16 Sep 2011 08:13:25 +0000 morgdave http://www.mypharma-editions.com/?p=21004 http://www.mypharma-editions.com/lutte-contre-le-cancer-ge-healthcare-va-investir-un-milliard-de-dollars/feed 0 http://www.mypharma-editions.com/les-metaux-lourds-au-secours-de-l%e2%80%99immunite http://www.mypharma-editions.com/les-metaux-lourds-au-secours-de-l%e2%80%99immunite#comments Fri, 16 Sep 2011 07:34:00 +0000 morgdave http://www.mypharma-editions.com/?p=21001 http://www.mypharma-editions.com/les-metaux-lourds-au-secours-de-l%e2%80%99immunite/feed 0 http://www.mypharma-editions.com/ab-science-feu-vert-de-la-fda-pour-son-etude-de-phase-3-sur-masitinib-dans-l%e2%80%99asthme-severe http://www.mypharma-editions.com/ab-science-feu-vert-de-la-fda-pour-son-etude-de-phase-3-sur-masitinib-dans-l%e2%80%99asthme-severe#comments Wed, 14 Sep 2011 16:20:17 +0000 morgdave http://www.mypharma-editions.com/?p=20981 http://www.mypharma-editions.com/ab-science-feu-vert-de-la-fda-pour-son-etude-de-phase-3-sur-masitinib-dans-l%e2%80%99asthme-severe/feed 0 http://www.mypharma-editions.com/bioalliance-pharma-resultats-positifs-pour-sa-biotherapie-amep%c2%ae-dans-le-melanome-metastatique http://www.mypharma-editions.com/bioalliance-pharma-resultats-positifs-pour-sa-biotherapie-amep%c2%ae-dans-le-melanome-metastatique#comments Wed, 14 Sep 2011 07:59:24 +0000 morgdave http://www.mypharma-editions.com/?p=20955 http://www.mypharma-editions.com/bioalliance-pharma-resultats-positifs-pour-sa-biotherapie-amep%c2%ae-dans-le-melanome-metastatique/feed 0 http://www.mypharma-editions.com/premier-modele-humain-pour-la-maladie-neurodegenerative-de-sanfilippo http://www.mypharma-editions.com/premier-modele-humain-pour-la-maladie-neurodegenerative-de-sanfilippo#comments Tue, 13 Sep 2011 15:49:00 +0000 morgdave http://www.mypharma-editions.com/?p=20948 http://www.mypharma-editions.com/premier-modele-humain-pour-la-maladie-neurodegenerative-de-sanfilippo/feed 0 http://www.mypharma-editions.com/cancer-nanobiotix-demarre-un-essai-clinique-avec-son-produit-nbtxr3 http://www.mypharma-editions.com/cancer-nanobiotix-demarre-un-essai-clinique-avec-son-produit-nbtxr3#comments Tue, 13 Sep 2011 12:44:25 +0000 morgdave http://www.mypharma-editions.com/?p=20937 http://www.mypharma-editions.com/cancer-nanobiotix-demarre-un-essai-clinique-avec-son-produit-nbtxr3/feed 0 http://www.mypharma-editions.com/diabete-de-type-2-nouvelles-donnees-positives-pour-lyxumia%c2%ae-et-lantus%c2%ae-de-sanofi http://www.mypharma-editions.com/diabete-de-type-2-nouvelles-donnees-positives-pour-lyxumia%c2%ae-et-lantus%c2%ae-de-sanofi#comments Mon, 12 Sep 2011 13:13:07 +0000 morgdave http://www.mypharma-editions.com/?p=20895 http://www.mypharma-editions.com/diabete-de-type-2-nouvelles-donnees-positives-pour-lyxumia%c2%ae-et-lantus%c2%ae-de-sanofi/feed 1 http://www.mypharma-editions.com/cancers-du-sein-un-nouveau-marqueur-du-risque-de-metastases-pulmonaires http://www.mypharma-editions.com/cancers-du-sein-un-nouveau-marqueur-du-risque-de-metastases-pulmonaires#comments Sat, 10 Sep 2011 15:23:38 +0000 morgdave http://www.mypharma-editions.com/?p=20883 http://www.mypharma-editions.com/cancers-du-sein-un-nouveau-marqueur-du-risque-de-metastases-pulmonaires/feed 0 http://www.mypharma-editions.com/amyotrophie-spinale-trophos-finalise-le-recrutement-des-patients-pour-son-etude-sur-l%e2%80%99olesoxime http://www.mypharma-editions.com/amyotrophie-spinale-trophos-finalise-le-recrutement-des-patients-pour-son-etude-sur-l%e2%80%99olesoxime#comments Thu, 08 Sep 2011 15:34:12 +0000 morgdave http://www.mypharma-editions.com/?p=20857 http://www.mypharma-editions.com/amyotrophie-spinale-trophos-finalise-le-recrutement-des-patients-pour-son-etude-sur-l%e2%80%99olesoxime/feed 0 http://www.mypharma-editions.com/un-partenariat-france-argentine-dans-le-domaine-de-la-medecine-et-de-limmunologie http://www.mypharma-editions.com/un-partenariat-france-argentine-dans-le-domaine-de-la-medecine-et-de-limmunologie#comments Thu, 08 Sep 2011 11:03:21 +0000 morgdave http://www.mypharma-editions.com/?p=20852 http://www.mypharma-editions.com/un-partenariat-france-argentine-dans-le-domaine-de-la-medecine-et-de-limmunologie/feed 0 http://www.mypharma-editions.com/sclerose-en-plaques-ab-science-recrute-le-premier-patient-dans-l%e2%80%99etude-de-phase-3-du-masitinib http://www.mypharma-editions.com/sclerose-en-plaques-ab-science-recrute-le-premier-patient-dans-l%e2%80%99etude-de-phase-3-du-masitinib#comments Wed, 07 Sep 2011 07:13:43 +0000 morgdave http://www.mypharma-editions.com/?p=20798 http://www.mypharma-editions.com/sclerose-en-plaques-ab-science-recrute-le-premier-patient-dans-l%e2%80%99etude-de-phase-3-du-masitinib/feed 0 http://www.mypharma-editions.com/psoriasis-feu-vert-de-l%e2%80%99afssaps-pour-une-etude-clinique-de-phase-ii-de-l%e2%80%99inecalcitol-d%e2%80%99hybrigenics http://www.mypharma-editions.com/psoriasis-feu-vert-de-l%e2%80%99afssaps-pour-une-etude-clinique-de-phase-ii-de-l%e2%80%99inecalcitol-d%e2%80%99hybrigenics#comments Tue, 06 Sep 2011 14:10:42 +0000 morgdave http://www.mypharma-editions.com/?p=20786 http://www.mypharma-editions.com/psoriasis-feu-vert-de-l%e2%80%99afssaps-pour-une-etude-clinique-de-phase-ii-de-l%e2%80%99inecalcitol-d%e2%80%99hybrigenics/feed 0 http://www.mypharma-editions.com/troubles-de-la-fertilite-un-regulateur-situe-dans-le-cerveau http://www.mypharma-editions.com/troubles-de-la-fertilite-un-regulateur-situe-dans-le-cerveau#comments Tue, 06 Sep 2011 11:55:26 +0000 morgdave http://www.mypharma-editions.com/?p=20772 http://www.mypharma-editions.com/troubles-de-la-fertilite-un-regulateur-situe-dans-le-cerveau/feed 0 http://www.mypharma-editions.com/douleur-theralpha-recoit-un-soutien-de-255-million-deuros-pour-developper-un-nouveau-medicament http://www.mypharma-editions.com/douleur-theralpha-recoit-un-soutien-de-255-million-deuros-pour-developper-un-nouveau-medicament#comments Tue, 06 Sep 2011 07:41:37 +0000 morgdave http://www.mypharma-editions.com/?p=20768 http://www.mypharma-editions.com/douleur-theralpha-recoit-un-soutien-de-255-million-deuros-pour-developper-un-nouveau-medicament/feed 2 http://www.mypharma-editions.com/1ere-autotransfusion-de-globules-rouges-crees-a-partir-de-cellules-souches http://www.mypharma-editions.com/1ere-autotransfusion-de-globules-rouges-crees-a-partir-de-cellules-souches#comments Fri, 02 Sep 2011 09:18:40 +0000 morgdave http://www.mypharma-editions.com/?p=20738 http://www.mypharma-editions.com/1ere-autotransfusion-de-globules-rouges-crees-a-partir-de-cellules-souches/feed 1